Home › NCT06840288

Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

Patients with peripheral lung tumors (primary or metastatic) that have been or will be ablated via robotic bronchoscopy.

Exclusion Criteria:

Patients with planned bronchoscopic ablations of peripheral lung tumors that were aborted for technical reasons (ablation was not completed).

About the study

To aggregate, integrate, and analyze data facilitating the study of MD Anderson patients with a known diagnosis of lung cancer or metastases to the lungs who undergo robotic assisted bronchoscopic ablation of peripheral tumors.

Sponsor: M.D. Anderson Cancer Center · Participants: 250 · Started: Feb 19, 2025

Contact the study team

• Roberto F Casal, MD · Phone: (713) 792-6238

Official record on ClinicalTrials.gov — NCT06840288

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.